Skip to main content
TALK
NASDAQ Industrial Applications And Services

Talkspace Presents Strong 2025 Financial Guidance and Details AI Strategy at J.P. Morgan Healthcare Conference

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.83
Mkt Cap
$634.463M
52W Low
$2.22
52W High
$4.355
52W Position info
73% above low
Off High info
12% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

TALK sits 73% above its 52-week low of $2.22.

Summary

Talkspace, Inc. presented its 2025 financial guidance, projecting strong revenue and Adjusted EBITDA growth, and detailed its strategic focus on AI-driven mental health solutions at the J.P. Morgan Healthcare Conference.


Key Events · Earnings and Guidance · TALK

  • 2025 Financial Guidance Provided

    Talkspace projects 2025 revenue guidance of $226-230 million and Adjusted EBITDA guidance of $14-16 million, reflecting a 24% revenue CAGR from 2022-2025E and 115% YoY Adjusted EBITDA growth.

  • Strategic Focus on AI in Mental Health

    The company introduced its 'first purpose-built mental health LLM' AI agent, trained on extensive clinical data with HIPAA protection and continuous clinical oversight, aiming to expand access and improve patient care.

  • Growth Strategy Outlined

    Talkspace detailed its systematic formula for growth, including increasing customer awareness, driving high-intent referrals, developing strategic payor partnerships, improving the patient journey, and expanding its offerings.


Analysis · TALK · Industrial Applications And Services

Talkspace's presentation at the J.P. Morgan Healthcare Conference provides a comprehensive update on its strategic direction and financial outlook. The 2025 guidance, projecting significant revenue and Adjusted EBITDA growth, indicates a positive trajectory for the company. The detailed emphasis on its proprietary AI agent, positioned as a clinically grounded and safe solution for mental health support, highlights a key strategic differentiator and potential growth driver. This focus on AI, combined with established growth strategies like payor partnerships and patient journey improvements, suggests a clear path for expanding market penetration and enhancing service offerings. Investors will likely view the strong financial projections and innovative AI strategy as positive indicators for future performance and market leadership in virtual behavioral health.

At the time of this filing, TALK was trading at $3.83 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $634.5M. The 52-week trading range was $2.22 to $4.36. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TALK - Latest Insights

TALK
May 29, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.20
Real-time Price: $5.21 info
Change: +$0.0100 (+0.19%) info
Market Cap: $872.74M info
TALK
May 29, 2026, 9:13 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.20
Real-time Price: $5.21 info
Change: +$0.0102 (+0.20%) info
Market Cap: $872.74M info
TALK
May 11, 2026, 5:11 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $5.18
Real-time Price: $5.21 info
Change: +$0.030 (+0.58%) info
Market Cap: $872.74M info
TALK
May 11, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.19
Real-time Price: $5.21 info
Change: +$0.020 (+0.39%) info
Market Cap: $872.74M info
TALK
Apr 20, 2026, 4:05 PM EDT
Filing Type: DEFM14A
Importance Score:
9
Price at Filing: $5.18
Real-time Price: $5.21 info
Change: +$0.030 (+0.58%) info
Market Cap: $872.74M info